Detalhe da pesquisa
1.
An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.
Nat Immunol
; 23(1): 50-61, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853448
2.
Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells.
J Autoimmun
; 132: 102888, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049437
3.
Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma.
Mol Ther
; 26(6): 1471-1481, 2018 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628306
4.
Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver.
Mol Ther
; 26(11): 2553-2566, 2018 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217730
5.
Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity.
Clin Immunol
; 188: 94-102, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305966
6.
Optimizing T-cell receptor gene therapy for hematologic malignancies.
Blood
; 127(26): 3305-11, 2016 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207802
7.
Engineered T cells can fight malignant T cells.
Blood
; 126(8): 927-8, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294714
8.
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
J Immunol
; 194(3): 1080-9, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539815
9.
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Haematologica
; 101(4): 482-90, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802053
10.
Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
Respir Res
; 17(1): 140, 2016 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793198
11.
Therapeutic potential of Tregs to treat rheumatoid arthritis.
Semin Immunol
; 23(3): 195-201, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21880506
12.
No hiding place for BOB inside myeloma.
Blood
; 129(10): 1236-1237, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280042
13.
Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.
Proc Natl Acad Sci U S A
; 108(52): 21176-81, 2011 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160697
14.
Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
Blood
; 118(2): 319-29, 2011 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606483
15.
CD3 limits the efficacy of TCR gene therapy in vivo.
Blood
; 118(13): 3528-37, 2011 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750319
16.
Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination.
Blood
; 117(25): 6813-24, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21447831
17.
Synthetic Cell-Based Immunotherapies for Neurologic Diseases.
Neurol Neuroimmunol Neuroinflamm
; 10(5)2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385738
18.
Modifications outside CDR1, 2 and 3 of the TCR variable ß domain increase TCR expression and antigen-specific function.
Front Immunol
; 14: 1148890, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122739
19.
Challenges in T cell receptor gene therapy.
J Gene Med
; 14(6): 386-99, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22610778
20.
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
Proc Natl Acad Sci U S A
; 106(45): 19078-83, 2009 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19884493